Next Article in Journal
Impact of a Novel Prioritization Framework on Clinician-Led Oncology Drug Submissions
Previous Article in Journal
Personalizing Post-Treatment Cancer Care: A Cross-Sectional Survey of the Needs and Preferences of Well Survivors of Breast Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Article

A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy

by 1,*, 2 and 3
1
Faculty of Medicine, University of British Columbia, 317–2194 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
2
Biomedical Branch Library, University of British Columbia, Vancouver, BC, Canada
3
Ottawa Integrative Cancer Centre, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(2), 4261; https://doi.org/10.3747/co.26.4261
Received: 5 January 2019 / Revised: 2 February 2019 / Accepted: 9 March 2019 / Published: 1 April 2019
Objectives: In cancer patients, chemotherapy-induced peripheral neuropathy (cipn) is a common complication, characterized by pain, loss of sensation, and numbness. Medical treatment for peripheral neuropathies has been shown to be ineffective for cipn. Acupuncture has been shown to be safe and effective in treating cancer-related symptoms and other peripheral neuropathies. For the present review, we aimed to evaluate the efficacy of acupuncture for the treatment of cipn. Design: Comprehensive searches for relevant studies were conducted in Ovid embase, the Web of Science, Ovid medline, the Cochrane Central Register of Controlled Trials (central), cinahl (ebsco Information Services, Ipswich, MA, U.S.A.), and the ClinicalTrials.gov Web site. References from previous systematic reviews were also searched. Additional trials were found in the reference lists of relevant papers and in searches of Google Scholar and acupuncturespecific Web sites. Included studies were randomized controlled trials (rcts) of any type of acupuncture used to treat patients with cipn. Results: Three clinical trials (203 participants) were included. Two studies found acupuncture to be effective in alleviating cipn pain and improving quality of life. One study found no benefit in improving neuropathic pain, symptoms, or quality of life. Study quality was variable and included a moderate overall risk of bias. Conclusions: The evidence is insufficient to recommend acupuncture for the treatment or prevention of cipn. Further research is needed to evaluate the effects of acupuncture in the treatment of cipn. Given that acupuncture is considered safe and might provide relief for patients, it can be considered at the clinician’s discretion.
Keywords: acupuncture; systematic reviews; chemotherapy-induced peripheral neuropathy; cipn; integrative oncology acupuncture; systematic reviews; chemotherapy-induced peripheral neuropathy; cipn; integrative oncology
MDPI and ACS Style

Li, K.; Giustini, D.; Seely, D. A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy. Curr. Oncol. 2019, 26, 4261. https://doi.org/10.3747/co.26.4261

AMA Style

Li K, Giustini D, Seely D. A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy. Current Oncology. 2019; 26(2):4261. https://doi.org/10.3747/co.26.4261

Chicago/Turabian Style

Li, Kevin, D. Giustini, and D. Seely. 2019. "A Systematic Review of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy" Current Oncology 26, no. 2: 4261. https://doi.org/10.3747/co.26.4261

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop